Celldex Therapeutics, Inc.CLDXNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, above historical average, modest growth trend.
Left:
||||
Free cash flow yield
Latest
-9.81%
↑ 80% above average
Average (9y)
-48.78%
Historical baseline
Range
High:-3.75%
Low:-242.76%
CAGR
+4.1%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -9.81% | -72.8% |
| 2023 | -5.68% | -12.4% |
| 2022 | -5.05% | -34.6% |
| 2021 | -3.75% | +53.6% |
| 2020 | -8.08% | +94.5% |
| 2019 | -145.73% | +40.0% |
| 2018 | -242.76% | -771.3% |
| 2017 | -27.86% | +13.5% |
| 2016 | -32.22% | -372.5% |
| 2015 | -6.82% | - |